What’s New

Latest News

an illustration of a man sitting on the ground holding his head with his profile and brain in the background
Research Summary
Only 19.1% of First-Episode Psychosis Patients Adhere to Antipsychotics
10/06/2026
Brionna Mendoza
Young people beginning antipsychotic treatment after first-episode psychosis had low medication adherence, according to a retrospective US cohort study published in JAMA Network Open.
Young people beginning antipsychotic treatment after first-episode psychosis had low medication adherence, according to a retrospective US cohort study published in JAMA Network Open.
Young people beginning...
10/06/2026
Psych Congress Network
Psych Congress Network
a physician fills out a discharge form while speaking to a patient
Research Summary
Early Ocrelizumab Shows Sustained Long-Term Benefit in Relapsing MS
10/06/2026
Maria Mantas
Treatment with ocrelizumab for up to 10 years was associated with sustained relapse control and minimal disability accrual in patients with relapsing MS, according to phase 3 findings.
Treatment with ocrelizumab for up to 10 years was associated with sustained relapse control and minimal disability accrual in patients with relapsing MS, according to phase 3 findings.
Treatment with ocrelizumab for...
10/06/2026
Neurology
Neurology
News
Part B MACs Propose Noncoverage for Fluorescence Wound Imaging 
10/05/2026
Jeffrey D. Lehrman, DPM, FASPS, MAPWCA, CPC, CPMA
Proposed local coverage determinations from all 7 Part B Medicare Administrative Contractors would designate real-time fluorescence wound imaging for bacterial presence as a noncovered service. Stakeholders can submit comments through...
Proposed local coverage determinations from all 7 Part B Medicare Administrative Contractors would designate real-time fluorescence wound imaging for bacterial presence as a noncovered service. Stakeholders can submit comments through...
Proposed local coverage...
10/05/2026
Wounds
Wounds
News
US Analysis Highlights Prior Authorization Burden Across Health Plans
10/02/2026
Grace Taylor, MS, MA
A US health policy analysis found widespread prior authorization use and substantial administrative burden, with electronic processing emerging as the leading reform strategy to improve efficiency and access to oncology care.
A US health policy analysis found widespread prior authorization use and substantial administrative burden, with electronic processing emerging as the leading reform strategy to improve efficiency and access to oncology care.
A US health policy analysis...
10/02/2026
Journal of Clinical Pathways
Journal of Clinical Pathways
FDA Approval
FDA Expands Pirtobrutinib to First-Line Treatment of CLL/SLL Without 17p Deletion
10/02/2026
Stephanie Holland
Based on results from BRUIN CLL-313, the FDA approved pirtobrutinib for previously untreated CLL/SLL without a known 17p deletion, establishing a first-line treatment option supported by a significant progression-free survival benefit over...
Based on results from BRUIN CLL-313, the FDA approved pirtobrutinib for previously untreated CLL/SLL without a known 17p deletion, establishing a first-line treatment option supported by a significant progression-free survival benefit over...
Based on results from BRUIN...
10/02/2026
Oncology
Oncology
Behind the Bill
CMS Finalizes GLOBE Model Linking Medicare Part B Drug Rebates to International Prices
10/02/2026
Grace Taylor, MS, MA
The Centers for Medicare & Medicaid Services (CMS) has finalized the Global Benchmark for Efficient Drug Pricing (GLOBE) Model, linking certain Medicare Part B drug rebates to international prices in an effort to lower federal spending and...
The Centers for Medicare & Medicaid Services (CMS) has finalized the Global Benchmark for Efficient Drug Pricing (GLOBE) Model, linking certain Medicare Part B drug rebates to international prices in an effort to lower federal spending and...
The Centers for Medicare &...
10/02/2026
First Report Managed Care
First Report Managed Care
News
Olanzapine Tablets Recalled Due to Failed Impurities Specifications
10/01/2026
Rebecca Amrick
Olanzapine tablets are under a voluntary Class III recall after the product failed to meet impurities specifications, affecting 22 032 bottles.
Olanzapine tablets are under a voluntary Class III recall after the product failed to meet impurities specifications, affecting 22 032 bottles.
Olanzapine tablets are under a...
10/01/2026
Pharmacy Learning Network
Pharmacy Learning Network

Latest Research

EPLD October 2026 cover.
EP Lab Digest
Advancing Complex Arrhythmia Care With Dual-Energy Ablation
Vol. 26, Issue 10, Issue October 2026
First Report Managed Care
First Report Managed Care
Improving Care Transitions to Reduce Avoidable Emergency Department Use
Vol. 23, Issue 3, Issue October 2026

HMP Global Learning Network

Featured Interviews

Jeffrey M. Cohen, MD
Videos
Targeting Type 2 Inflammation in Eczema, Prurigo Nodularis, and Urticaria
10/01/2026
Jeffrey M. Cohen, MD; Riya Gandhi, MA
Dr Jeffrey Cohen discusses how IL-4, IL-13, and IL-31 drive inflammation and itch across eczema, prurigo nodularis, and chronic urticaria.
Dr Jeffrey Cohen discusses how IL-4, IL-13, and IL-31 drive inflammation and itch across eczema, prurigo nodularis, and chronic urticaria.
Dr Jeffrey Cohen discusses how...
10/01/2026
The Dermatologist
Hara Oyedeji, DNP, PMHNP-BC, MSEd
Clinical Pearls
Improving Sleep-Wake Assessment in Major Depressive Disorder
09/29/2026
Hara Oyedeji, APRN, PHMNP-BC, MS Ed
Hara Oyedeji, DNP, PMHNP-BC, MSEd, provides an overview of the relationship between sleep-wake disruptions and major depressive disorder (MDD).
Hara Oyedeji, DNP, PMHNP-BC, MSEd, provides an overview of the relationship between sleep-wake disruptions and major depressive disorder (MDD).
Hara Oyedeji, DNP, PMHNP-BC,...
09/29/2026
Psych Congress NP Institute
Tanios Bekaii-Saab, MD, and Jonathan Catrona, PA-C
Videos
New GI Cancer Standards Emerging From ASCO 2026: Part 1
09/28/2026
Tanios Bekaii-Saab, MD, FACP; Jonathan Catrona, PA-C
Tanios Bekaii-Saab, MD, chair of the Department of Hematology and Oncology at Mayo Clinic in Arizona, and Jonathan Catrona, PA-C, of New York Cancer & Blood Specialists, discuss emerging GI cancer research out of the ASCO 2026 Annual Meeting...
Tanios Bekaii-Saab, MD, chair of the Department of Hematology and Oncology at Mayo Clinic in Arizona, and Jonathan Catrona, PA-C, of New York Cancer & Blood Specialists, discuss emerging GI cancer research out of the ASCO 2026 Annual Meeting...
Tanios Bekaii-Saab, MD, chair of...
09/28/2026
Oncology Learning Network APP Institute
Cheat sheets and alphabet soup certification courses can make or break you, but regular peds practice helps you conquer the court case.
Videos
Pediatric Video Tutorial: Crashing Kids, Cheat Sheets & Conquering Court
09/25/2026
Scott DeBoer, RN, MSN, CPEN, CEN, CCRN, CFRN
Cheat sheets and alphabet soup certification courses can make or break you, but regular peds practice helps you conquer the court case.
Cheat sheets and alphabet soup certification courses can make or break you, but regular peds practice helps you conquer the court case.
Cheat sheets and alphabet soup...
09/25/2026
EMSWorld
Raj Chovatiya
Videos
Chronic Spontaneous Urticaria: Type 2 Inflammation and Mast Cell Hyperreactivity
09/01/2026
Raj Chovatiya, MD, PhD; Riya Gandhi, MA
Dr Raj Chovatiya explains how type 2 inflammation drives mast cell activation in chronic spontaneous urticaria (CSU), highlighting the roles of IL-4, IL-13, and IgE in both immune and neuroimmune pathways.
Dr Raj Chovatiya explains how type 2 inflammation drives mast cell activation in chronic spontaneous urticaria (CSU), highlighting the roles of IL-4, IL-13, and IgE in both immune and neuroimmune pathways.
Dr Raj Chovatiya explains how...
09/01/2026
The Dermatologist
Desiree Matthews, PMHNP-BC
Clinical Pearls
Individualizing Initial Antidepressant Selection for Major Depressive Disorder
08/31/2026
Desiree Matthews, PHMNP-BC
Desiree Matthews, PMHNP-BC, offers a framework for choosing an initial antidepressant agent for major depressive disorder.
Desiree Matthews, PMHNP-BC, offers a framework for choosing an initial antidepressant agent for major depressive disorder.
Desiree Matthews, PMHNP-BC,...
08/31/2026
Psych Congress NP Institute
A “sensory ambulance” is now actively in use by the neo-peds transport team from Golisano Children's Hospital in Southwest Florida. Here’s a behind-the-scenes tour as to how insights from parents, children, and EMS professionals helped create and customize the ambulance.
Videos
Pediatric Video Tutorial: 'Sensory Ambulances'—Amazing for Autism
08/25/2026
Scott DeBoer, RN, MSN, CPEN, CEN, CCRN, CFRN
A “sensory ambulance” is now actively in use by the neo-peds transport team from Golisano Children's Hospital in Southwest Florida.
A “sensory ambulance” is now actively in use by the neo-peds transport team from Golisano Children's Hospital in Southwest Florida.
A “sensory ambulance” is now...
08/25/2026
EMSWorld
Amy paller
Videos
Clinical Management of Atopic Dermatitis Across Childhood
08/01/2026
Amy S. Paller, MD, MS; Riya Gandhi, MA
Dr Amy Paller discusses how advances in understanding type 2 inflammation are transforming pediatric atopic dermatitis care.
Dr Amy Paller discusses how advances in understanding type 2 inflammation are transforming pediatric atopic dermatitis care.
Dr Amy Paller discusses how...
08/01/2026
The Dermatologist
Murugiah_title_slide
Author Interview
Adoption of Intravascular Imaging Use Among Intermediate to High-Volume Operators in the United States From 2019 to 2023: A Medicare Data Analysis — An Interview With Karthik Murugiah, MBBS, MHS
07/31/2026
Karthik Murugiah, MBBS, MHS
Dr Karthik Murugiah shares background and insights on his article, “Adoption of Intravascular Imaging Use Among Intermediate to High-Volume Operators in the United States From 2019 to 2023: A Medicare Data Analysis.”
Dr Karthik Murugiah shares background and insights on his article, “Adoption of Intravascular Imaging Use Among Intermediate to High-Volume Operators in the United States From 2019 to 2023: A Medicare Data Analysis.”
Dr Karthik Murugiah shares...
07/31/2026
Journal of Invasive Cardiology
Erin Crown, MHS, PA-C, CAQ-Psychiatry
Clinical Pearls
When to Adjust or Augment Antidepressant Treatment in MDD
07/31/2026
Erin Crown, MHS, PA-C, CAQ
In this video, Erin Crown, MHS, PA-C, CAQ-Psychiatry, shares her approach to deciding when to augment rather than switch antidepressant therapy. 
In this video, Erin Crown, MHS, PA-C, CAQ-Psychiatry, shares her approach to deciding when to augment rather than switch antidepressant therapy. 
In this video, Erin Crown, MHS,...
07/31/2026
Psych Congress NP Institute

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use